Find the right fit for you - faster
Get tailored insights about working at ItherX in one quick step.
ItherX Snapshot
Either cancer or hepatitis will get what's coming to it from ItherX Pharmaceuticals. The biotechnology drug development firm has focused its efforts on discovering treatments in two areas: oncology and virology. In the field of virology, ItherX Pharmaceuticals is developing compounds to fight the hepatitis C virus (HCV) at the earliest stages of infection by blocking entry of the virus into healthy cells. The company also has research programs for cell-based oncology therapies. ItherX Pharmaceuticals, formerly Immusol, changed its name in 2008.
